Osaka, Japan

Kiyoshi Nagata


Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kiyoshi Nagata: Innovator in Pharmaceutical Compounds

Introduction

Kiyoshi Nagata is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the expression of apolipoprotein AI. With a total of 4 patents to his name, Nagata's work has implications for medical advancements.

Latest Patents

Nagata's latest patents include a method of enhancing the expression of apolipoprotein AI using olefin derivatives. This patent provides compounds that enhance the expression of apoAI, featuring specific chemical formulas that include various aromatic groups and linkers. Another notable patent focuses on the utilities of amide compounds, which are also aimed at enhancing the expression of apoAI and are intended for use as medicaments.

Career Highlights

Kiyoshi Nagata is currently employed at Shionogi & Company Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a deep understanding of chemical compounds and their applications in medicine.

Collaborations

Nagata has collaborated with notable coworkers such as Teruo Yamamori and Natsuki Ishizuka, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kiyoshi Nagata's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…